InsiderTrades

Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.

Accepted 2021-08-09 00:00:00 ET · period of report 2021-08-06 · accession 0001735276-21-000078 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-08-09 2021-08-06 ALNY Greenstreet Yvonne Pres, COO S - Sale+OE $199.00 -53.1K 11.0K -83% -$10.56M
DM 2021-08-09 2021-08-06 ALNY Greenstreet Yvonne Pres, COO M - OptEx $77.10 +53.1K 64.1K +481% +$4.09M
DM 2021-08-09 2021-08-06 ALNY Greenstreet Yvonne Pres, COO M - OptEx $0.00 -53.1K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-06 S D 53,064 $199.00 11,023 D — —
2 Common Common Stock 2021-08-06 M A 28,064 $77.10 39,087 D — —
3 Common Common Stock 2021-08-06 M A 25,000 $77.10 64,087 D — —
4 Derivative Stock Option (right to buy) 2021-08-06 M D 28,064 $0.00 0 D $77.10 · — to 2026-09-18 28,064 Common Stock (F3) The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
5 Derivative Performance Stock Option 2016 (right to buy) 2021-08-06 M D 25,000 $0.00 0 D $77.10 · 2018-08-13 to 2026-09-18 25,000 Common Stock